Von Hoff DD - Search Results

1

Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion.

Kuhn JG, Von Hoff DD, Hersh M, Melink T, Clark GM, Weiss GR, Coltman CA. Kuhn JG, et al. Among authors: von hoff dd. Eur J Cancer Clin Oncol. 1989 May;25(5):797-803. doi: 10.1016/0277-5379(89)90123-5. Eur J Cancer Clin Oncol. 1989. PMID: 2737217

2

A phase I trial of taxol given by a 6-hour intravenous infusion.

Brown T, Havlin K, Weiss G, Cagnola J, Koeller J, Kuhn J, Rizzo J, Craig J, Phillips J, Von Hoff D. Brown T, et al. J Clin Oncol. 1991 Jul;9(7):1261-7. doi: 10.1200/JCO.1991.9.7.1261. J Clin Oncol. 1991. PMID: 1675263 Clinical Trial.

3

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule.

Von Hoff DD, Kuhn JG, Havlin KA, Langevin AM, Brown TD, Weiss GR, Turner JN, Purvis J, Lucas VS, Bair KW, et al. Von Hoff DD, et al. Cancer Res. 1990 Dec 1;50(23):7496-500. Cancer Res. 1990. PMID: 2253197

4

Phase I trial and biochemical evaluation of tiazofurin administered on a weekly schedule.

Melink TJ, Sarosy G, Hanauske AR, Phillips JL, Bayne JH, Grever MR, Jayaram HN, Von Hoff DD. Melink TJ, et al. Among authors: von hoff dd. Sel Cancer Ther. 1990 Spring;6(1):51-61. doi: 10.1089/sct.1990.6.51. Sel Cancer Ther. 1990. PMID: 2343202

5

A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U).

Weiss GR, Sarosy GA, Shenkenberg TD, Williams T, Clendeninn NJ, Von Hoff DD, Woolley JL, Liao SH, Blum MR. Weiss GR, et al. Among authors: von hoff dd. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1867-73. doi: 10.1016/0277-5379(89)90360-x. Eur J Cancer Clin Oncol. 1989. PMID: 2632268

6

Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).

Arteaga CL, Brown TD, Kuhn JG, Shen HS, O'Rourke TJ, Beougher K, Brentzel HJ, Von Hoff DD, Weiss GR. Arteaga CL, et al. Among authors: von hoff dd. Cancer Res. 1989 Aug 15;49(16):4648-53. Cancer Res. 1989. PMID: 2743343

7

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase II pilot study.

Havlin KA, Kuhn JG, Myers JW, Ozols RF, Mattox DE, Clark GM, von Hoff DD. Havlin KA, et al. Among authors: von hoff dd. Cancer. 1989 Feb 1;63(3):423-7. doi: 10.1002/1097-0142(19890201)63:3<423::aid-cncr2820630304>3.0.co;2-c. Cancer. 1989. PMID: 2912521

8

Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide.

Dorr FA, Kuhn JG, Phillips J, von Hoff DD. Dorr FA, et al. Among authors: von hoff dd. Eur J Cancer Clin Oncol. 1988 Nov;24(11):1699-706. doi: 10.1016/0277-5379(88)90070-3. Eur J Cancer Clin Oncol. 1988. PMID: 3208814

9

A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.

Weiss GR, Kuhn JG, Rizzo J, Smith LS, Rodriguez GI, Eckardt JR, Burris HA 3rd, Fields S, VanDenBerg K, von Hoff DD. Weiss GR, et al. Among authors: von hoff dd. Cancer Chemother Pharmacol. 1995;35(5):397-402. doi: 10.1007/s002800050253. Cancer Chemother Pharmacol. 1995. PMID: 7850921 Clinical Trial.

10

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

Rothenberg ML, Eckardt JR, Kuhn JG, Burris HA 3rd, Nelson J, Hilsenbeck SG, Rodriguez GI, Thurman AM, Smith LS, Eckhardt SG, Weiss GR, Elfring GL, Rinaldi DA, Schaaf LJ, Von Hoff DD. Rothenberg ML, et al. Among authors: von hoff dd. J Clin Oncol. 1996 Apr;14(4):1128-35. doi: 10.1200/JCO.1996.14.4.1128. J Clin Oncol. 1996. PMID: 8648367 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters